Co-administration of genistein with doxorubicin-loaded polypeptide nanoparticles weakens the metastasis of malignant prostate cancer by amplifying oxidative damage.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biomaterials Science

• Publication date

  2018-03-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c7bm01201bPMID 29480308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Cell Membrane‐Coated Gold Nanocages with Hyperthermia‐Triggered Drug Release and Homotypic Target Inhibit Growth and Metastasis of Breast Cancer

  2020cited by this paper
• Bortezomib Increases the Cancer Therapeutic Efficacy of Poly(amino acid)-Doxorubicin.

  2017cited by this paper
• pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.

  2017cited by this paper
• Cancer statistics, 2017

  2017cited by this paper
• Carbon dots for tracking and promoting the osteogenic differentiation of mesenchymal stem cells.

  2017cited by this paper
• Synergistic therapy of chemotherapeutic drugs and MTH1 inhibitors using a pH-sensitive polymeric delivery system for oral squamous cell carcinoma.

  2017cited by this paper
• Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.

  2017cited by this paper
• Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).

  2017cited by this paper
• Oxidative Stress Promotes Doxorubicin‐Induced Pgp and BCRP Expression in Colon Cancer Cells Under Hypoxic Conditions

  2017cited by this paper
• Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.

  2017cited by this paper
• Curcumin-encapsulated polymeric nanoparticles for metastatic osteosarcoma cells treatment

  2017cited by this paper
• Targeted hydroxyethyl starch prodrug for inhibiting the growth and metastasis of prostate cancer.

  2017cited by this paper
• Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein

  2016cited by this paper
• Supplemental materials for: Solid Tumor Therapy Using a Cannon and Pawn Combination Strategy

  2016cited by this paper
• Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes.

  2016cited by this paper
• A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy.

  2016cited by this paper
• Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling.

  2016cited by this paper
• Understanding genistein in cancer: The "good" and the "bad" effects: A review.

  2016cited by this paper
• Genistein induces apoptosis by down-regulating thioredoxin-1 in human hepatocellular carcinoma SNU-449 cells.

  2016cited by this paper
• Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.

  2015cited by this paper
• Reactive oxygen species in cancer: a dance with the devil.

  2015cited by this paper
• Multicomponent 5-fluorouracil loaded PAMAM stabilized-silver nanocomposites synergistically induce apoptosis in human cancer cells.

  2015cited by this paper
• Oxidative stress inhibits distant metastasis by human melanoma cells

  2015cited by this paper
• Metastasis and Oxidative Stress: Are Antioxidants a Metabolic Driver of Progression?

  2015cited by this paper
• Emerging antitumor applications of extracellularly reengineered polymeric nanocarriers.

  2015cited by this paper
• Systemic Targeting of Lymph Node Metastasis through the Blood Vascular System by Using Size-Controlled Nanocarriers.

  2015cited by this paper
• Polymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with inflammation.

  2014cited by this paper
• Nanodiamonds enhance therapeutic efficacy of doxorubicin in treating metastatic hormone-refractory prostate cancer

  2014cited by this paper
• Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.

  2014cited by this paper
• Genistein Alleviates Radiation-Induced Pneumonitis by Depressing Ape1/Ref-1 Expression to Down-regulate Inflammatory Cytokines

  2014cited by this paper
• Oxidative Stress and Nucleic Acid Oxidation in Patients with Chronic Kidney Disease

  2013cited by this paper
• Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.

  2013cited by this paper
• DNA Repair and Cancer Therapy: Targeting APE1/Ref-1 Using Dietary Agents

  2012cited by this paper
• Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.

  2011cited by this paper
• Sensitizing effect of silencing Ape1/Ref-1 on doxorubicin-induced apoptosis in human carcinoma cells

  2011cited by this paper
• Human AP-endonuclease (APE1/Ref-1) and its acetylation regulate YB-1/p300 recruitment and RNA polymerase II loading in the drug induced activation of multidrug resistance gene MDR1

  2010cited by this paper
• Essential role of DNA base excision repair on survival in an acidic tumor microenvironment.

  2009cited by this paper
• Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress: use of APE1 small molecule inhibitors to delineate APE1 functions.

  2009cited by this paper
• Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.

  2009cited by this paper
• APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.

  2009cited by this paper
• Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth.

  2008cited by this paper
• Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene MDR1

  2008cited by this paper
• Nuclear oxidative damage correlates with poor survival in colorectal cancer

  2008cited by this paper
• Dietary genistein inhibits metastasis of human prostate cancer in mice.

  2008cited by this paper
• Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems.

  2008cited by this paper
• Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.

  2007cited by this paper
• The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.

  2007cited by this paper
• Impact of diet on prostate cancer: a review

  2005cited by this paper
• Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model.

  2005cited by this paper
• Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.

  2001cited by this paper

• Histone lactatation-related genes GPR19 and SLC22A16 are important diagnostic markers and drug treatment targets for prostate cancer.

  2026cites this paper
• Phytochemical Triad in Lung Cancer: Synergistic Mechanisms and Clinical Translation of Genistein, Piperine, and Resveratrol

  2025cites this paper
• Genistein as a Chemo-modulatory Agent: Exploring its Potential in Chemosensitization and Combinatorial Therapeutic Strategies for Cancer Treatment.

  2025cites this paper
• Updated Review on Natural Polyphenols: Molecular Mechanisms, Biological Effects, and Clinical Applications for Cancer Management

  2025cites this paper
• Genistein Improves the Cytotoxic, Apoptotic, and Oxidative-Stress-Inducing Properties of Doxorubicin in SK-MEL-28 Cancer Cells

  2025cites this paper
• Recent advancements in genistein nanocarrier systems for effective cancer management

  2025cites this paper
• Nano-phytochemical-based formulations as promising opportunities for prostate cancer therapy and management: a comprehensive narrative review

  2025cites this paper
• Targeting the DNA damage response (DDR) of cancer cells with natural compounds derived from Panax ginseng and other plants

  2024cites this paper
• Genistein Induces Ferroptosis in Colorectal Cancer Cells via FoxO3/SLC7A11/GPX4 Signaling Pathway

  2024cites this paper
• QbD-driven Formulation Development and Evaluation of Genistein Nanoparticles for Prostate Cancer.

  2024cites this paper
• The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens

  2024cites this paper
• PLGA nanomedical consignation: A novel approach for the management of prostate cancer.

  2024cites this paper
• New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials.

  2023cites this paper
• Recent advances and future perspectives in the therapeutics of prostate cancer

  2023cites this paper
• Aristolochic acid I aggravates oxidative stress-mediated apoptosis by inhibiting APE1/Nrf2/HO-1 signaling

  2023cites this paper
• Genistein: a promising modulator of apoptosis and survival signaling in cancer

  2023cites this paper
• Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety.

  2023cites this paper
• Daidzein ameliorates doxorubicin-induced cardiac injury by inhibiting autophagy and apoptosis in rats.

  2022cites this paper
• Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper

  2022influential citation
• Regulation of Cell Signaling Pathways by Genistein in Different Cancers: Progress, Prospects and Pitfalls.

  2022cites this paper
• A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment

  2022cites this paper
• Phenylboronic acid conjugated mPEG-b-PCL micelles as DOX carriers for enhanced drug encapsulation and controlled drug release

  2022cites this paper
• Chemotherapeutics activities of dietary phytoestrogens against prostate cancer: From observational to clinical studies.

  2022cites this paper
• High Concentrations of Genistein Decrease Cell Viability Depending on Oxidative Stress and Inflammation in Colon Cancer Cell Lines

  2022cites this paper
• Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology

  2022cites this paper
• Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer

  2022cites this paper
• Role of Plant-Derived Flavonoids in Cancer Treatment

  2022cites this paper
• Dietary Phenolic Compounds as Anticancer Natural Drugs: Recent Update on Molecular Mechanisms and Clinical Trials

  2022cites this paper
• Genistein suppresses the inflammation and GSK-3 pathway in an animal model of spontaneous ovarian cancer

  2021cites this paper
• Epithelial protein lost in neoplasm (EPLIN) and prostate cancer: lessons learned from the ARCaP model.

  2021cites this paper
• All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis.

  2021cites this paper
• Decapeptide Modified Doxorubicin Loaded Solid Lipid Nanoparticles as Targeted Drug Delivery System against Prostate Cancer.

  2021cites this paper
• Genistein as a regulator of signaling pathways and microRNAs in different types of cancers

  2021cites this paper
• Current Perspectives on the Beneficial Effects of Soybean Isoflavones and Their Metabolites for Humans

  2021cites this paper
• Ovarian cancer has the third-highest incidence of gynecological cancer in women

  2021cites this paper
• Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis.

  2021cites this paper
• Genistein enhances cytotoxic and antimigratory activities of doxorubicin on 4T1 breast cancer cells through cell cycle arrest and ROS generation

  2020cites this paper
• A rationally designed polymer conjugate for tumor-specific amplification of oxidative stress and boosting anti-tumor immunity.

  2020cites this paper
• Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma.

  2020cites this paper
• Phytoestrogens for Cancer Prevention and Treatment

  2020cites this paper
• Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells

  2020cites this paper
• Flavonoids in cancer therapy: current and future trends

  2020cites this paper
• ROLE OF FLAVONOIDS AGAINST ADRIAMYCIN TOXICITY.

  2020cites this paper
• Sexual hormones regulate the redox status and mitochondrial function in the brain. Pathological implications

  2020cites this paper
• Co-delivery of dual chemo-drugs with precisely controlled, high drug loading polymeric micelles for synergistic anti-cancer therapy.

  2019cites this paper
• Impregnation of Curcumin into a Biodegradable (Poly-lactic-co-glycolic acid, PLGA) Support, to Transfer Its Well Known In Vitro Effect to an In Vivo Prostate Cancer Model

  2019cites this paper
• Tangeretin-Assisted Platinum Nanoparticles Enhance the Apoptotic Properties of Doxorubicin: Combination Therapy for Osteosarcoma Treatment

  2019cites this paper
• One-pot synthesis of carbon dots with intrinsic folic acid for synergistic imaging-guided photothermal therapy of prostate cancer cells.

  2019cites this paper